Mylan may have overcharged taxpayers by $1.27 billion for EpiPens, HHS says
Mylan may have overcharged taxpayers as much as $1.27 billion over 10 years for its signature EpiPens, according to an analysis released Wednesday.
Mylan CEO defends EpiPen cost to angry lawmakers
The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers.
Clinton offers plan to prevent ‘excessive’ drug price hikes
Following the public outcry over steep increases in price for an emergency allergy treatment, Hillary Clinton is pledging to better protect patients from such costs.
Watch 7:41
Did outcry on social media lead to Mylan’s generic EpiPen?
After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half the market price of the original. The New…
Identical to the original product -- a pre-filled syringe containing epinephrine, used for life-threatening allergic reactions -- the generic will cost $300 for two.
Mylan’s “EpiPen4Schools” program, begun in August 2012, offers free or discounted EpiPens to schools.
Additional Support Provided By:
